Pharmaceuticals

Quadrivalent Industry Poised for Rapid Growth, Forecast to Touch $15.37 Billion by 2030 at 10.1% CAGR

February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the quadrivalent market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Quadrivalent Market?

The quadrivalent market size has shown substantial growth recently. It is forecast to grow from $9.51 billion in 2025 to $10.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.8%. The increase observed historically can be linked to the rising prevalence of influenza, government-led vaccination campaigns, progress in vaccine research, heightened public awareness regarding flu prevention, and the early adoption of quadrivalent vaccines in developed regions.

The quadrivalent market is projected to experience swift expansion in the coming years, with its valuation anticipated to reach $15.37 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.1%. This growth during the forecast period is driven by several factors, including an increased need for comprehensive influenza protection, advancements in vaccine delivery systems, the broadening of immunization initiatives in developing economies, augmented investments in biotechnology and precision medicine, as well as supportive reimbursement strategies and governmental aid. Key trends shaping the forecast period encompass optimization of vaccine formulations, broader immunization programs targeting various age groups, innovations in cold chain logistics and distribution, enhanced multi-strain influenza coverage, and rigorous regulatory compliance alongside quality assurance efforts.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9335&type=smp

Which Drivers Are Supporting The Rise Of The Quadrivalent Market?

The global increase in immunization coverage is anticipated to propel the quadrivalent market. This coverage signifies the proportion of a population that has received specific or recommended vaccines within a specified period. As immunization coverage expands, it drives heightened demand for vaccines, with quadrivalent vaccines, which offer protection against four strains, frequently being integrated into routine vaccination programs to address multiple disease threats in a single shot. For instance, in July 2025, the World Health Organization, an international public health organization based in Switzerland, reported that global coverage for the first dose of the HPV vaccine in girls grew from 27% in 2023 to 31% in 2024. Therefore, rising immunization coverage across the world will drive quadrivalent market growth going forward.

What Segments Are Identified Within The Structure Of The Quadrivalent Market?

The quadrivalent market covered in this report is segmented –

1) By Type: Intradermal Shot, Intramuscular Injection, Nasal Spray

2) By Technology: Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies

3) By Disease: Cancer, Hepatitis, Pneumococcal Disease, COVID-19, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Other Diseases

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospital And Pharmacy, Government Suppliers, Other Channels (NGOs)

Subsegments:

1) By Intradermal Shot: Standard Intradermal Injection, Needle-Free Intradermal Delivery

2) By Intramuscular Injection: Standard Intramuscular Injection, Adjuvanted Intramuscular Injection

3) By Nasal Spray: Live Attenuated Nasal Spray, Inactivated Nasal Spray

Which Innovation Trends Are Advancing Developments Within The Quadrivalent Market?

Leading companies within the quadrivalent market are increasingly concentrating on safer, innovative methods for vaccine delivery, such as nano-particle technology, to enhance their market revenues. This nano-particle technology replicates the external structure of the virus using virus-like particles (VLPs) without incorporating live genetic material, thereby boosting safety and the immune response. For example, in March 2024, Cadila Pharmaceuticals, an India-based pharmaceutical company, launched its advanced Quadrivalent Influenza Vaccine, a sophisticated immunization engineered to offer protection against four distinct strains of the influenza virus, specifically two A strains (H1N1 and H3N2) and two B strains. This quadrivalent formulation boosts the vaccine’s effectiveness by targeting a wider spectrum of circulating influenza viruses, making it particularly potent during flu seasons. The aQIV aims to stimulate a robust immune response, which in turn reduces the incidence of influenza-related morbidity and mortality. Its development signifies ongoing efforts to improve public health outcomes in response to evolving viral strains.

Which Key Players Are Driving Competition In The Quadrivalent Market?

Major companies operating in the quadrivalent market are AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Pfizer Inc., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG)

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

Which Region Is Projected To Lead The Quadrivalent Market During The Forecast Period?

North America was the largest region in the quadrivalent market in 2025. The regions covered in the quadrivalent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Quadrivalent Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9335&type=smp

Browse Through More Reports Similar to the Global Quadrivalent Market 2026, By The Business Research Company

Quadrivalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

Pentavalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Pentavalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795